Quest 10 Wealth Builders’s ResMed RMD Stock Holding History

Quest 10 Wealth Builders’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$438	–	836
2025 Q4	$438	Hold	2	–	–	﹤0.01%	693
2025 Q3	$498	Hold	2	–	–	﹤0.01%	772
2025 Q2	$470	Hold	2	–	–	﹤0.01%	684
2025 Q1	$407	Buy	+2	New	+$467	﹤0.01%	672

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Quest 10 Wealth Builders's RMD Position: Q1 2026 in Review

Quest 10 Wealth Builders sold out of ResMed (RMD) in Q1 2026, closing a stake of 2 shares — an estimated $438 sold.

Quest 10 Wealth Builders first reported a position in RMD in Q1 2025 and held it in 4 quarters. The position peaked at $498 in Q3 2025. 945 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Quest 10 Wealth Builders reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Quest 10 Wealth Builders sold 2 ResMed shares in Q1 2026, an estimated $438.
Quest 10 Wealth Builders first reported a position in ResMed in Q1 2025 and held it in 4 quarters.
Quest 10 Wealth Builders's ResMed position peaked at $498 in Q3 2025.
945 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q1 2026, filed 6 May 2026.